Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.40
+0.05 (0.11%)
At close: Mar 24, 2026

TPE:6657 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-258.4-231.08-260.38-265.66-120.24
Depreciation & Amortization
22.5722.7623.7824.3522.85
Other Amortization
-0.050.050.060.06
Loss (Gain) From Sale of Assets
0.01-0.22--
Asset Writedown & Restructuring Costs
0.05----
Stock-Based Compensation
17.5614.8514.8711.094.92
Other Operating Activities
-0.68-0.72-1.04-0.010.46
Change in Accounts Receivable
-0.540.080.61-0.790.31
Change in Inventory
-0.160.04-0.150.16-0.02
Change in Accounts Payable
0.08-0.03-0.030.070.02
Change in Unearned Revenue
-----0.04
Change in Other Net Operating Assets
-2.8913.35-2.97-2.12-5.6
Operating Cash Flow
-222.41-180.71-225.05-232.84-97.29
Capital Expenditures
-2.31-0.75-0.84-6.45-8.9
Sale (Purchase) of Intangibles
-0.02---0.14-
Investment in Securities
95.47192.11-58.11182-107
Other Investing Activities
-1.321.87-00.13
Investing Cash Flow
91.83193.23-58.96175.42-115.76
Long-Term Debt Repaid
-6.07-6.2-6.52-6.51-6.79
Net Debt Issued (Repaid)
-6.07-6.2-6.52-6.51-6.79
Issuance of Common Stock
434.29151.49446.944.75294.65
Repurchase of Common Stock
-28.89----
Other Financing Activities
----0.13
Financing Cash Flow
399.34145.29440.42-1.75287.98
Foreign Exchange Rate Adjustments
-0.160.09---
Net Cash Flow
268.6157.9156.41-59.1874.94
Free Cash Flow
-224.72-181.47-225.89-239.29-106.18
Free Cash Flow Margin
-2928.30%-2341.79%-3155.81%-3255.16%-1417.84%
Free Cash Flow Per Share
-2.54-2.38-3.14-3.59-1.77
Cash Interest Paid
0.460.210.210.210.28
Cash Income Tax Paid
0.630.850.53-0.09-0.06
Levered Free Cash Flow
-131.5-110.26-129.83-148.4-57.24
Unlevered Free Cash Flow
-131.21-110.13-129.69-148.27-57.06
Change in Working Capital
-3.5113.43-2.55-2.67-5.33
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.